Your browser doesn't support javascript.
loading
An economic model to assess the value of triclosan-coated sutures in reducing the risk of surgical site infection in a mastectomy in India.
Mahajan, Nilesh S; Pillai, Reshmi; Chopra, Hitesh; Grover, Ajay; Kohli, Ashish.
Afiliação
  • Mahajan NS; Medical Affairs, Clinical Operations and Device Safety, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India.
  • Pillai R; Medical Affairs, Clinical Operations and Device Safety, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India.
  • Chopra H; Ethicon Sales and Marketing Team, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India.
  • Grover A; Ethicon Sales and Marketing Team, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India.
  • Kohli A; Ethicon Sales and Marketing Team, Johnson and Johnson Pvt. Ltd, Jogeshwari (East), Mumbai, Maharashtra, India.
Indian J Cancer ; 2021 Sep 19.
Article em En | MEDLINE | ID: mdl-35017366
ABSTRACT

BACKGROUND:

The comparison of triclosan-coated sutures (TCS) was made with conventional nonantimicrobial-coated sutures (NCS) to reduce surgical site infection (SSI). This study demonstrates the efficacy and economic outcome of TCS versus NCS for SSIs in mastectomy in India.

METHODS:

In this retrospective analysis, 100 patients were included for both conditions-TCS and NCS-from a private and public hospital in India. A systematic literature search of available evidence for both SSI incidences and TCS efficacy data in India were gathered. We collected cost data from a private and public hospital, respectively, for mastectomy in India. The cost-effectiveness of TCS in comparison with the conventional NCS was calculated using a decision-tree deterministic model. We performed a one-way sensitivity analysis to compare TCS with NCS.

RESULTS:

Cost savings with the use of TCS increased with an increase in SSI incidence and an increase in efficacy for mastectomies in both public and private hospitals. We found a base cost saving of Indian rupees (INR) 27,299 at a private hospital and INR 2,958 at a public hospital for mastectomies. The incremental cost of TCS suture was 0.01% in a private hospital whereas 0.17% in a public hospital.

CONCLUSION:

The use of TCS resulted in reduced SSI incidence and cost savings for mastectomy in India.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Indian J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Indian J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia